This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Scott Henry
Vice President of Nonclinical Development at Ionis Pharmaceuticals, Inc.

Agenda Sessions

Safety Issues Related to Chemically Modified Oligos and Conjugates
16:30
View Session

Speakers at this event

Dominic Hoepfner, Ph.D.

Scientist

Novartis Institutes for BioMedical Research

Scott HenryVice President of Nonclinical Development at Ionis Pharmaceuticals, Inc.

Agenda Sessions

Speakers at this event

See Scott Speak

Scott Henry
Vice President of Nonclinical Development at Ionis Pharmaceuticals, Inc.